logo
logo

AppliedVR Secures $29 Million in Series A Funding to Make Virtual Reality the Standard of Care for Chronic Pain

Mar 23, 2021•over 4 years ago

Amount Raised

$29 Million

Round Type

series a

Los Angeles

Description

AppliedVR, a pioneer advancing the next generation of digital medicine, today announced $29 million in series A funding, bringing its total funds raised to date to $35 million. The round, which includes key investors F-Prime Capital, JAZZ Venture Partners, Sway Ventures, GSR Ventures, Magnetic Ventures and Cedars-Sinai, will fuel the company’s growth as it pursues full FDA approval over the next year.

Company Information

Company

Applied Vr

Location

Los Angeles, California, United States

About

Led by co-founders Matthew Stoudt and Josh Sackman, AppliedVR is a leader in immersive therapeutics, pioneering virtual reality-based treatments that address the complexity of pain and other conditions. Rooted in a science-backed, clinically validated program, the company's flagship immersive therapeutic device3 for chronic pain is the first VR-based prescription therapeutic to receive FDA Breakthrough Device Designation. Offering a comprehensive approach that addresses multiple pain indicators, the solution enables patients to change the way they process pain and develop new, positive habits and coping skills that improve quality of life. Founded in 2015, AppliedVR is headquartered in Los Angeles and was recently named a 2021 Fast Company Most Innovative Company. For more information, visit appliedvr.io.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People